You are here: Industry Insights > hypertension

News List

Astrazeneca Completes Divestment Agreement with Atnahs americanpharmaceuticalreview
March 04, 2020
AstraZeneca has completed the previously communicated agreement with Atnahs Pharma (Atnahs) to divest its global commercial rights to Inderal (propranolol) ...
AstraZeneca sells hypertension medicines to Atnahs Pharma pharmaceutical-technology
March 03, 2020
AstraZeneca has divested global commercial rights to a total of five hypertension drugs to Atnahs Pharma for a consideration of $350m.
Drugs for TB, hypertension and antacids amongst those failing quality tests firstwordpharma
December 25, 2019
In addition, a batch of Bengal Chemicals & Pharmaceuticals' amlodipine has also failed the assay test, while one batch of its antibiotic metronidazole also couldn't pass the dissolution test.
Long Working Hours May Up Risk for Masked, Sustained HTN drugs
December 24, 2019
Long working hours are an independent risk factor for masked and sustained hypertension, according to a study published online in Hypertension.
Quantum Genomics Initiates its Trial in Difficult-to-Treat and Resistant Hypertension americanpharmaceuticalreview
December 23, 2019
Quantum Genomics announced the initiation of its pivotal Phase III FRESH study (Firibastat in treatment-RESistant Hypertension) in difficult-to-treat1 and resistant2 hypertension.
Kidney Donation Linked to Increased Hypertension Risk drugs
September 23, 2019
Kidney donation is associated with an increased risk for hypertension, according to a study published online in the Clinical Journal of the American Society of Nephrology.
Netarsudil Lowers IOP in Glaucoma, Ocular Hypertension drugs
September 02, 2019
Netarsudil ophthalmic solution (0.02 percent; once daily) significantly reduced mean intraocular pressure (IOP) among patients with open-angle glaucoma...
BP From Midlife to Late Life Tied to Risk for Subsequent Dementia drugs
August 14, 2019
The risk for subsequent dementia is significantly increased for blood pressure patterns of midlife and late-life hypertension as well as midlife hypertension and late-life hypotension...
Unichem Laboratories gets US FDA nod for hypertension management expresspharma
August 13, 2019
Drug firm Unichem Laboratories has received approval from the US health regulator to market Chlorthalidone tablets, used to treat high blood pressure.
New ACC/AHA Guidelines Detect More Cases of Gestational Hypertension drugs
July 23, 2019
Adopting the 2017 American College of Cardiology/American Heart Association guidelines for hypertension resulted in an increase in the prevalence of high blood pressure in pregnant women...

Previous page 1 2 3 Next page